New Treatment Options for Children with Peanut Allergies: How It Works, Results and What to Expect

New treatment options for children with peanut allergies can help raise the amount of peanut protein a child may tolerate before reacting, reducing the risk from accidental exposure. These treatments do not currently cure peanut allergy and should only be considered with a pediatric allergy specialist and an emergency plan.

Overview: What Are the New Treatment Options for Children With Peanut Allergies?

New treatment options for children with peanut allergies focus on changing how the immune system responds to small, carefully controlled amounts of peanut protein. The best-established option is peanut oral immunotherapy (OIT), a specialist-led program in which a child receives gradually increasing doses over time. It is designed to reduce the risk of a serious reaction after an accidental exposure, rather than to allow unrestricted peanut consumption.

Peanut allergy can cause symptoms ranging from hives, vomiting and coughing to severe breathing or circulation problems. Because reactions can be unpredictable, children with a diagnosed peanut allergy should continue strict avoidance of peanut-containing foods and follow their emergency action plan unless their allergy clinician advises otherwise.

Other approaches are being studied or used in selected settings, including peanut skin patches and biologic medicines that reduce allergic responsiveness. These options may be appropriate for some children, but availability, approval status and suitability differ by country, age and individual medical history.

How Peanut Oral Immunotherapy Works

In peanut oral immunotherapy, the child starts with an extremely small measured amount of peanut protein. The amount is increased gradually at scheduled clinic visits if the previous dose has been tolerated. The goal is desensitization: increasing the threshold at which an allergic reaction may occur.

After reaching a maintenance dose, the child usually takes that dose at home every day for an extended period, with regular follow-up. Continued daily exposure is important because protection may lessen if treatment is stopped. OIT changes risk management; it does not reliably create permanent tolerance for every child.

A pediatric allergist should assess the child before treatment and provide written instructions about dosing, meals, exercise, illness and what to do if symptoms develop. Families should understand that accidental reactions remain possible, including after a dose that was previously tolerated.

Who May Be a Candidate for Treatment?

Potential candidates are children with a confirmed peanut allergy who can attend repeated appointments, follow a daily treatment routine and have caregivers able to recognize and manage allergic reactions. Confirmation commonly involves a detailed allergy history, skin-prick testing or blood testing, and sometimes a medically supervised oral food challenge.

Suitability depends on more than test results. The specialist considers the child’s age, reaction history, asthma control, other allergies, digestive symptoms, ability to cooperate with treatment and the family’s goals. Poorly controlled asthma may increase the risk of serious reactions and generally needs to be addressed before considering OIT.

Some children may not be suitable for OIT, or may decide that continued avoidance is the better option. This is a valid, effective management strategy when supported by education, label reading, an emergency medication plan and ongoing allergy follow-up.

What Happens During the Procedure and Recovery Timeline?

The process begins with an allergy consultation and shared decision-making discussion. If OIT is chosen, the first doses and each planned dose increase are typically given in a medical setting, where the child is observed for symptoms. The child then continues the assigned daily dose at home until the next escalation visit.

The dose-building phase may take months, depending on the protocol and whether the child experiences reactions or missed doses. Once the maintenance dose is reached, treatment continues over the longer term. Families should not change the dose, restart after a prolonged interruption or try peanut exposure at home without instructions from their allergy team.

On dosing days, clinicians may advise avoiding vigorous exercise, hot baths or other factors that can increase absorption or make reactions more likely around the dose. Doses may need special consideration during fever, viral illness, asthma flare-ups or significant stomach symptoms. The allergy team will give individualized guidance.

Children generally return to normal school and daily activities, but peanut avoidance and access to prescribed emergency medication remain essential. The practical benefit is often greater confidence that an accidental small exposure is less likely to cause a severe reaction, not freedom from precautions.

Benefits, Risks and Realistic Results

For many appropriately selected children, OIT can increase the amount of peanut protein tolerated during a supervised challenge compared with avoidance alone. This may lower the chance of reacting to small unintended exposures in foods or shared environments. It can also help some families feel more prepared in daily life.

However, side effects are common, especially during dose increases. Mild mouth itching, stomach pain, nausea, hives or throat discomfort can occur. More serious allergic reactions, including anaphylaxis, are possible and require prompt treatment according to the child’s emergency plan.

A small number of children develop persistent digestive symptoms that need evaluation, including eosinophilic esophagitis, an inflammatory condition of the esophagus. Treatment may need to be paused or stopped if concerning symptoms occur. Benefits and burdens should be reviewed regularly with the allergy specialist.

There is no single success rate that applies to every child because studies use different ages, doses and definitions of success. A child may achieve a higher reaction threshold yet still react to larger amounts of peanut. The most meaningful outcome is an individualized reduction in accidental-exposure risk achieved safely and sustainably.

What Is the Newest Treatment for Peanut Allergies?

Peanut oral immunotherapy is the most established newer treatment approach for children with confirmed peanut allergy. It uses daily, measured peanut protein under medical supervision to build desensitization. In some countries, standardized oral immunotherapy products are approved for certain pediatric age groups, while other programs use carefully designed specialist protocols.

Biologic medicines are also an important development in food-allergy care. Some are used to reduce allergic reactions from accidental exposure to one or more foods in eligible people, rather than treating peanut allergy alone. They are given under medical guidance and may be considered when the allergy pattern, age and medical history support their use.

Peanut skin patch immunotherapy remains under investigation or has limited availability depending on location. It delivers very small amounts of allergen through the skin and may have a different balance of convenience and effectiveness than OIT. A pediatric allergist can explain which evidence-based options are accessible and appropriate locally.

Does NAET Actually Work?

NAET, often described as a combination of allergy testing, acupressure or acupuncture and exposure-based techniques, has not been shown in high-quality clinical evidence to diagnose or treat peanut allergy reliably. It should not be used as a substitute for allergy testing by a qualified clinician, medically supervised food challenges or evidence-based treatment.

A child with peanut allergy may have a severe reaction even after alternative treatments that claim to remove the allergy. Families should continue peanut avoidance and carry prescribed emergency medication unless a pediatric allergist has formally reassessed the allergy using accepted methods.

If a family is considering any complementary approach, it is safest to discuss it openly with the child’s allergy clinician. This helps prevent delayed care, unsafe food reintroduction or confusion about the emergency plan.

What Is the Latest Study on Peanut Allergies in Children?

Recent research continues to examine how early food introduction, oral immunotherapy, skin-based immunotherapy and biologic medicines may prevent or reduce the impact of food allergy. Studies of OIT generally support its ability to increase reaction thresholds in many children while also confirming that treatment-related reactions and ongoing daily commitment are important considerations.

Research is also exploring whether starting treatment at younger ages may offer advantages for selected children, and how to make treatment safer and more convenient. These findings are promising, but they do not mean every child should start therapy. Decisions should be based on the child’s confirmed diagnosis, health status and the experience of the treating allergy service.

Families can ask their clinician about current clinical trials or newly approved therapies, but should be cautious about headlines suggesting a universal cure. The most reliable advances are those evaluated in well-designed studies and incorporated into professional allergy guidelines.

When to Seek Medical Care

Emergency medical care is needed if a child develops trouble breathing, wheezing, repetitive coughing, throat tightness, voice changes, faintness, marked sleepiness, widespread hives with other symptoms, or persistent vomiting after possible peanut exposure. Caregivers should use prescribed epinephrine promptly when the child’s action plan indicates it and seek emergency help afterward.

A non-urgent allergy appointment is appropriate for suspected reactions to peanut, uncertainty about test results, new symptoms after eating, difficulty managing avoidance at school or home, or interest in immunotherapy. Parents should not test whether a child has outgrown peanut allergy by offering peanut at home.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals can assess and treat children with food allergies for international patients. A pediatric allergy consultation can help families establish a clear diagnosis, emergency plan and individualized discussion of treatment options.

Frequently asked questions

Can peanut allergy be cured in children?

There is currently no guaranteed permanent cure for peanut allergy. Some children naturally outgrow it, while others may develop desensitization through supervised treatment. Even after successful treatment, continued precautions are usually needed.

How long does peanut oral immunotherapy take?

The dose-escalation phase commonly takes several months, although timing varies between protocols and children. Maintenance treatment then usually continues long term. Missed doses, illness or reactions can alter the schedule.

Can a child eat peanuts after oral immunotherapy?

Not necessarily. The main goal is protection from accidental exposure, not unrestricted peanut eating. The child's allergist will explain whether peanut-containing foods may be included and in what form or amount.

Is peanut oral immunotherapy safe?

It can be safe when prescribed and monitored by an experienced allergy team, but it has real risks. Allergic reactions can happen during treatment, including severe reactions. Families need training, reliable follow-up and access to prescribed emergency medication.

What should parents do if they suspect a peanut allergy?

Parents should arrange assessment with a qualified clinician or pediatric allergist. They should avoid giving peanut again until they receive advice, especially if a previous reaction involved breathing symptoms, vomiting, widespread hives or faintness. Testing and, when appropriate, a supervised food challenge can clarify the diagnosis.

Can food allergy blood tests alone diagnose peanut allergy?

No. Blood tests and skin-prick tests show sensitization, which does not always mean a child will react when eating the food. A clinician interprets test results alongside the child's history and may recommend a supervised oral food challenge when needed.

References

• American Academy of Allergy, Asthma & Immunology
• National Institute of Allergy and Infectious Diseases
• Food Allergy Research & Education
• European Academy of Allergy and Clinical Immunology
• World Allergy Organization

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.